Ethnicity and Socioeconomic Status Linked to Triple Negative Breast Cancer
Regardless of their socioeconomic status, black women seemed nearly twice as likely as white women to be diagnosed with triple-negative breast cancer, suggests research.
Regardless of their socioeconomic status, black women seemed nearly twice as likely as white women to be diagnosed with triple-negative breast cancer, suggests research.
The authors conclude that "Our data offer support for the clinical potential of CTCs to assess the individual risk of patients at the time of primary diagnosis and may be used for treatment tailoring in the absence of other strong quantitative markers." However, they note that although they used only two markers to detect CTCs, the identification of other markers could make CTCs even more useful in predicting metastases and guiding therapeutic choices.
In an accompanying editorial, Arnold M. Schwartz, M.D., Ph.D., of the Department of Pathology and Surgery and Norris Nolan, M.D., of the Department of Pathology at The George Washington University, Washington, DC, write that the work of Rack et al. is notable because of the large cohort, the focus on early breast cancer, and sampling both before and after treatment and that "The identification of CTCs represents an additional biomarker that provides insight into clinical behavior."
More Questions Than Answers in Breast Cancer Produced by Large Panel Genetic Testing
A team of researchers have found that powerful tests produce more questions than they answer while large genetic testing panels promise to uncover clues about patients with breast cancer.
A team of researchers have found that powerful tests produce more questions than they answer while large genetic testing panels promise to uncover clues about patients with breast cancer.
